مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
Normal view MARC view ISBD view

A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway. [electronic resource]

By:
  • Tiran, Zohar
Contributor(s):
  • Oren, Anat
  • Hermesh, Chen
  • Rotman, Galit
  • Levine, Zurit
  • Amitai, Hagit
  • Handelsman, Tal
  • Beiman, Merav
  • Chen, Aviva
  • Landesman-Milo, Dalit
  • Dassa, Liat
  • Peres, Yair
  • Koifman, Cynthia
  • Glezer, Sarit
  • Vidal-Finkelstein, Rinat
  • Bahat, Kobi
  • Pergam, Tania
  • Israel, Cylia
  • Horev, Judith
  • Tsarfaty, Ilan
  • Ayalon-Soffer, Michal
Producer: 20080916Description: 4612-21 p. digitalISSN:
  • 1078-0432
Subject(s):
  • Amino Acid Sequence
  • Animals
  • Apoptosis -- physiology
  • Blotting, Western
  • Electrophoresis, Polyacrylamide Gel
  • Flow Cytometry
  • Hepatocyte Growth Factor -- metabolism
  • Humans
  • Molecular Sequence Data
  • Protein Isoforms -- genetics
  • Proto-Oncogene Proteins c-met -- genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction -- physiology
  • Surface Plasmon Resonance
Online resources:
  • Available from publisher's website
In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 14
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.

A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.

APA

Tiran Z., Oren A., Hermesh C., Rotman G., Levine Z., Amitai H., Handelsman T., Beiman M., Chen A., Landesman-Milo D., Dassa L., Peres Y., Koifman C., Glezer S., Vidal-Finkelstein R., Bahat K., Pergam T., Israel C., Horev J., Tsarfaty I. & Ayalon-Soffer M. (20080916). A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Tiran Zohar, Oren Anat, Hermesh Chen, Rotman Galit, Levine Zurit, Amitai Hagit, Handelsman Tal, Beiman Merav, Chen Aviva, Landesman-Milo Dalit, Dassa Liat, Peres Yair, Koifman Cynthia, Glezer Sarit, Vidal-Finkelstein Rinat, Bahat Kobi, Pergam Tania, Israel Cylia, Horev Judith, Tsarfaty Ilan and Ayalon-Soffer Michal. 20080916. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Tiran Z., Oren A., Hermesh C., Rotman G., Levine Z., Amitai H., Handelsman T., Beiman M., Chen A., Landesman-Milo D., Dassa L., Peres Y., Koifman C., Glezer S., Vidal-Finkelstein R., Bahat K., Pergam T., Israel C., Horev J., Tsarfaty I. and Ayalon-Soffer M. (20080916). A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Tiran Zohar, Oren Anat, Hermesh Chen, Rotman Galit, Levine Zurit, Amitai Hagit, Handelsman Tal, Beiman Merav, Chen Aviva, Landesman-Milo Dalit, Dassa Liat, Peres Yair, Koifman Cynthia, Glezer Sarit, Vidal-Finkelstein Rinat, Bahat Kobi, Pergam Tania, Israel Cylia, Horev Judith, Tsarfaty Ilan and Ayalon-Soffer Michal. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20080916.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site